Biotechnology
China's Largest Plasmid and Virus Facility from GenScript in Operation
ZHENJIANG, China, Dec. 20, 2019 /PRNewswire/ -- The CDMO segment of the world's leading biotech company GenScript announced that GenScript's plasmid and virus facility was put into operation onDecember 18, 2019. It is a milestone on the path to industrialization of the gene and cell therapy indus...
2019-12-20 21:59
2764
Getinge to Acquire Applikon Biotechnology B.V., A Leading Company in the Fast Growing Area of Bioreactor Systems
GOTHENBURG, Sweden, Dec. 19, 2019 /PRNewswire/ -- Getinge announces today an agreement to acquire 100% of the shares in Applikon Biotechnology B.V. from Applikon Biotechnology Holding B.V. Applikon Biotechnology B.V. is a leading company in the fast growing area of advanced bioreactor systems for...
2019-12-19 18:27
15155
Asieris Wins Questex's Fierce Innovation Awards - Life Sciences Edition 2019
SHANGHAI, Dec. 19, 2019 /PRNewswire/ -- Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, announced today that it has been selected as a winner in this year's Fierce Innovation ...
2019-12-19 13:51
2634
MoA Technology implements CDD Vault to manage its crop protection research data
SAN FRANCISCO and OXFORD, England, Dec. 17, 2019 /PRNewswire/ -- MoA Technology Ltd (MoA Tech) and Collaborative Drug Discovery, Inc (CDD) announced today that MoA Tech teams are successfully running CDD Vault, a comprehensive informatics platform for archiving, mining and analysing chemistry and...
2019-12-17 17:00
1280
Novoheart Licenses Harvard Technology to Develop Next-Generation Human Heart-in-a-Jar
* Novoheart engineered the world's first "human heart-in-a-jar" as part of its proprietary MyHeart™ platform * Novoheart receives exclusive license from Harvard University to integrate pioneering bioreactor technology that accommodates model ventricles and optional valves into the "human hear...
2019-12-16 16:05
1808
HOYA Group PENTAX Medical Cleared CE Mark for DISCOVERY(TM), an AI Assisted Polyp Detector
TOKYO, Dec. 16, 2019 /PRNewswire/ -- PENTAX Medical, a division of the HOYA Group, announced that it has cleared CE mark for DISCOVERY™, an innovative Artificial Intelligence (AI) assisted polyp detector designed to support endoscopists in finding potential polyps during a colorectal examination....
2019-12-16 16:00
1822
Drug Manufacturers Eye Analytical Instrumentation to Reduce Operating Costs
SANTA CLARA, California, Dec. 12, 2019 /PRNewswire/ -- The total analytical instrumentation market in pharmaceuticals, biopharmaceuticals, and nutraceuticals generated revenues of $3.05 billion in 2018 and is expected to grow at aCAGR of 7.0% to touch $4.91 billion in 2025. Pharmaceuticals were t...
2019-12-12 23:11
1119
CStone completes registration filing for the Phase I trial of its tumor immune microenvironment modulator CS3005 to enable study initiation in Australia
SUZHOU, China, Dec. 12, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the Company has recently received the approval from the Human Research Ethics Committee (HREC) in Australia, and the acknowledgement from Australia's Therapeutic Goods ...
2019-12-12 14:47
3237
Biocon Biologics Symposium on '100 Years of Insulin - Delivering on Universal Access & Equitable Care' Resonates Well With Leading KOLs at IDF Congress 2019
BENGALURU, India, Dec. 12, 2019 /PRNewswire/ -- Biocon Biologics, a fully integrated 'pure play' global biosimilars organisation, brought together Key Opinion Leaders (KOLs), including physicians, scientists, healthcare professionals, government representatives, policy makers, and IDF members, at...
2019-12-12 09:00
1554
Human Microbiome Market to Reach $6.08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics
SANTA CLARA, California, Dec. 11, 2019 /PRNewswire/ -- There has been a surge in industry-academia collaborations in thehuman microbiome therapeutics space. The partnerships betweenpharma/biotech companies and academic institutes are bringing together the research expertise of educational organiz...
2019-12-11 23:55
904
AGC Biologics Expands Plasmid DNA Offering
SEATTLE, Dec. 11, 2019 /PRNewswire/ -- AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals, is significantly expanding its CDMO services with plasmid DNA (pDNA) offerings from itsHeidelberg site in Germany. With the demand for pDNA growing rap...
2019-12-11 09:06
2090
Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma
SYDNEY, Dec. 11, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it's lead program, GDC-0084, has been selected to join GBM AGILE, an international, academic-led, multi-drug adaptive phase ...
2019-12-11 08:41
6428
Ascentage Pharma Releases Updated Data of its Novel BCR-ABL Inhibitor, HQP1351, in an Oral Presentation Nominated for "Best of ASH"
SUZHOU, China and ROCKVILLE, Md., Dec. 11, 2019 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the updated results ...
2019-12-11 08:00
12235
Publication of First In-Human Data Reveals Safety & Efficacy of Tigilanol Tiglate in Solid Tumours
* First in-human Clinical Phase I study of intratumoural tigilanol tiglate (EBC-46) has been published in The Lancet's EBioMedicine journal; * An efficacious dose was achieved and a Maximum Tolerated Dose (MTD) was not reached, indicating tigilanol tiglate tolerability in humans; * Promising...
2019-12-09 21:01
1401
PRC NHC Issues New Policy on Cord Blood Banks, Implementation Rules To Be Provided
HONG KONG, Dec. 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today reported thatChina's National Health Commission ("NHC") ...
2019-12-06 20:00
15326
Global Cord Blood Corporation Announces Results of 2019 Annual General Meeting
HONG KONG, Dec. 5, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2019 Annual Gene...
2019-12-05 21:30
13366
Hummingbird Bioscience Raises US$19 Million in Series B Financing
SINGAPORE, Dec. 5, 2019 /PRNewswire/ -- Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery and development of new breakthrough precision antibody therapeutics for difficult-to-treat conditions, today announced that it has raisedUS$19 million in a Series B finan...
2019-12-05 10:00
1835
Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine
Newly updated and expanded NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic clarify who should be tested for cancer-causing genetic mutations Experts caution about risks of direct-to-consumer genetic testing and stress the importance of genetic counselin...
2019-12-04 22:01
958
PathogenDx Lauded by Frost & Sullivan for Its Game-changing DNA-based Multiplex Microarray Technology
PathogenDx's breakthrough technology shifts the pathogen detection paradigm from microbial to molecular testing through its microarray assays, namely Detect X, EnviroX, and QuantX SANTA CLARA, California, Dec. 3, 2019 /PRNewswire/ -- Based on its recent analysis of the global microbial DNA testin...
2019-12-03 22:00
1355
Gowan Company Announces Acquisition of Two New Active Ingredients, Fenamidone and Pencycuron, from Bayer AG
HARPENDEN, England, Dec. 3, 2019 /PRNewswire/ -- Gowan Crop Protection Limited, an affiliate of Gowan Company, L.L.C., announced today that it has entered into agreements with Bayer AG to acquire rights to the active ingredients Fenamidone and Pencycuron. The acquisition includes product regist...
2019-12-03 01:00
1346
Week's Top Stories
Most Reposted
Singapore-based video streaming provider teams up with renowned celebrity platform to provide much-needed boost for brands
[Picked up by 323 media titles]
2024-09-13 17:12
HS HYOSUNG Unveils New CI and Vision, Embracing "Star" and "Tree" Symbolism
[Picked up by 313 media titles]
2024-09-11 20:27FETC International's MD Dr. Y.C. Chang Honored with the "Master Entrepreneur Award" at APEA 2024
[Picked up by 306 media titles]
2024-09-16 11:50
VinCSS, A Vietnamese Startup, Becomes the World's First Company to Secure FIDO Device Onboarding (FDO) Certificates
[Picked up by 298 media titles]
2024-09-11 15:20
NATIONAL ENERGY AWARDS 2024 SHOWCASES MALAYSIA'S COMMITMENT TO ENERGY MANAGEMENT, ENERGY EFFICIENCY AND RENEWABLE ENERGY SOLUTIONS
[Picked up by 287 media titles]
2024-09-13 15:00
Most Read
VinCSS, A Vietnamese Startup, Becomes the World's First Company to Secure FIDO Device Onboarding (FDO) Certificates
2024-09-11 15:20
11481
HS HYOSUNG Unveils New CI and Vision, Embracing "Star" and "Tree" Symbolism
2024-09-11 20:27
11251
Mushiny Establishes Subsidiary in Japan and Showcases New Products at LTT Expo Empowering Local Partners: Mushiny's Deep Collaboration to Revolutionize the Future of Logistics
2024-09-10 17:12
7300
Circles and e& international mark one-year success of JV & digital telco leadership
2024-09-10 15:00
6771
InCorp Global Wins "Sustainability Champion" Award at PrimeGlobal's Golden Globes
2024-09-10 17:00
6748